Michael Fürst has 20 years of experience in corporate responsibility, social business and innovation, and integrity and compliance management, in business and academia. He is currently having responsibilities for the implementation of the Novartis CR and access to medicines strategy, inclusive business model innovation, innovative finance, ESG investor relations, measurement and evaluation, materiality and stakeholder engagement.